Evidence map›Paper›PMID 39519195›Full record

ArticleInternational journal of molecular sciences2024

Extracellular Hsp70 and Circulating Endometriotic Cells as Novel Biomarkers for Endometriosis.

Christiane Guder, Soraya Heinrich, Vanadin Seifert-Klauss, Marion Kiechle, Lisa Bauer, Rupert Öllinger, Andreas Pichlmair, Marie-Nicole Theodoraki, Veena Ramesh, Ali Bashiri Dezfouli and 3 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christiane GuderDepartment of Otholaryngology, Head and Neck Surgery, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.
Soraya HeinrichDepartment of Gynecology and Obstetrics, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.
Vanadin Seifert-KlaussDepartment of Gynecology and Obstetrics, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.
Marion KiechleDepartment of Gynecology and Obstetrics, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.ORCID 0000-0003-4237-2657
Lisa BauerRadiation Immuno-Oncology, TranslaTUM-Central Institute for Translational Cancer Research, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.ORCID 0000-0001-9455-0780
Rupert ÖllingerInstitute of Molecular Oncology and Functional Genomics, TranslaTUM-Central Institute for Translational Cancer Research, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.
Andreas PichlmairDepartment of Virology, TranslaTUM-Central Institute for Translational Cancer Research, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.ORCID 0000-0002-0166-1367
Marie-Nicole TheodorakiDepartment of Otholaryngology, Head and Neck Surgery, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.
Veena RameshDepartment of Otholaryngology, Head and Neck Surgery, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.
Ali Bashiri DezfouliDepartment of Otholaryngology, Head and Neck Surgery, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.
Barbara WollenbergDepartment of Otholaryngology, Head and Neck Surgery, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.ORCID 0000-0002-3062-459X
Alan Graham PockleyJohn van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.ORCID 0000-0001-9593-6431
Gabriele MulthoffRadiation Immuno-Oncology, TranslaTUM-Central Institute for Translational Cancer Research, TUM University Hospital, School of Medicine and Health, Technical University Munich, Ismaningerstr. 21, 81675 Munich, Germany.ORCID 0000-0002-2616-3137

Funding

BAYCELLator AZ-1568-22BMBF 02NUK064A
6 · The paper itself

Abstract

Stress-inducible heat shock protein 70 (Hsp70), which functions as a molecular chaperone and is frequently overexpressed in different cancer cell types, is present on the cell surface of tumor cells and is actively released into the circulation in free and extracellular lipid vesicle-associated forms. Since the exact pathomechanism of endometriosis has not yet been elucidated (although it has been associated with the development of endometrial and ovarian cancer), we asked whether extracellular Hsp70 and circulating endometriotic cells (CECs) reflect the presence and development of endometriosis. Therefore, circulating levels of free and lipid microvesicle-associated Hsp70 were measured using the Hsp70-exo ELISA, and the presence of circulating CECs in the peripheral blood of patients with endometriosis was determined using membrane Hsp70 (mHsp70) and EpCAM monoclonal antibody (mAb)-based bead isolation approaches. Isolated CECs were further characterized by immunofluorescence using reagents directed against cytokeratin (epithelial marker), CD45 (leukocyte marker), CD105/CD44 (mesenchymal stemness markers) and by comparative RNA analysis. Similar to the situation in patients with cancer, the levels of circulating Hsp70 were elevated in the blood of patients with histologically proven endometriosis compared to a healthy control cohort, with significantly elevated Hsp70 levels in endometriosis patients with lesions outside the uterine cavity. Moreover, CECs could be isolated using the cmHsp70.1 mAb-based, and to a lesser extent EpCAM mAb-based, bead approach in all patients with endometriosis, with the highest counts obtained using the mHsp70-targeting procedure in patients with extra-uterine involvement. The longevity in cell culture and the expression of the cytokeratins CD105 and CD44, together with differentially expressed genes related to epithelial-to-mesenchymal transition (EMT), revealed similarities between mHsp70-expressing CECs and circulating tumor cells (CTCs) and suggest a mesenchymal stem cell origin. These findings support the involvement of mHsp70-positive stem cell-like cells in the development of endometriotic lesions. In summary, elevated levels of Hsp70 and CECs in the circulation could serve as liquid biopsy markers for endometriosis with extra-uterine involvement and help to elucidate the underlying pathomechanism of the disease.

Indexed as

BiomarkersEndometriosisHSP70 Heat-Shock ProteinsAdultEndometriumFemaleHumansMiddle AgedBiomarkersHSP70 Heat-Shock Proteinsendometriosisheat shock protein 70 (Hsp70)mesenchymal stemness biomarker

Identifiers

PMID39519195
PMCPMC11546379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.